Rapid actions of vitamin D compounds
✍ Scribed by Ana R. de Boland; Dr. Ilka Nemere
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 486 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
The rapid actions of vitamin D compounds are surveyed in avariety of target tissues, including intestine, muscle, bone, hepatocytes, fibroblasts, HL-60 cells, kidney, mammary gland, and parathyroid. Evidence for non-nuclear receptors vs. membranophilic effects is discussed, followed by a consideration of signal transduction mechanisms including steroid hormone activated Ca2+ channels, phospholipid metabolism, protein kinases, and the role of G-proteins. o 1992 Wiley-Liss, ~nc.
📜 SIMILAR VOLUMES
## Abstract The biologically active metabolite of vitamin D, 1,25‐dihydroxyvitamin D~3~ (1,25(OH)~2~D~3~) is a secosteroid whose genomic mechanism of action is similar to that of other steroid hormones and is mediated by stereospecific interaction of 1,25(OH)~2~D~3~ with the vitamin D receptor (VDR
We and others have previously shown that selected vitamin D analogs potentiate the vitamin D receptor (VDR) mediated transcription much more efficiently than the natural hormone itself. Here we show that the transcriptionally active 20-epi analogs, namely KH 1060 and MC 1288, protect VDR against deg
A conformational analysis of two model compounds of vitamin D was carried out by means of theoretical computations, Ab initio calculations Ž . were carried out using the standard 6-31G\* basis set at the Hartree᎐Fock HF Ž . level of theory. In addition, the Møller᎐Plesset MP2 correlation treatment w